# Characterization of the Gut Microbiome of Patients with Clostridioides difficile Infection and Healthy Individuals in Greece

## TL;DR

This study compares gut microbiomes of people with Clostridioides difficile infection and healthy individuals in Greece, finding differences in bacterial composition.

## Contribution

The study provides a characterization of the gut microbiome in Greek CDI patients and healthy individuals using 16S rRNA sequencing.

## Key findings

- CDI patients had higher abundance of Firmicutes and Proteobacteria phyla.
- Enterococcus was dominant in CDI patients, while Faecalibacterium was most abundant in healthy individuals.
- Enterococcaceae and Enterococcus were more prevalent in CDI patients compared to healthy individuals.

## Abstract

Background/Objectives: The gut microbiome plays an important role in the colonization of an individual by Clostridioides difficile and in the development of Clostridioides difficile infection (CDI). The main purpose of this study was to compare the gut microbiomes of patients with CDI and healthy individuals. Methods: We prospectively included 48 individuals: 32 patients with CDI and 16 healthy individuals. Microbiomes were analyzed by sequencing the hypervariable regions of the 16S rRNA gene using an Ion GeneStudio™ S5 System. Further statistical analysis of microbiome data was performed with the open-source programming language R version 3.5.2. Results: Among the CDI patients, Firmicutes and Proteobacteria were the most abundant phyla, while Enterobacteriaceae and Enterococcaceae were the most abundant families. Genus-level analysis showed that Enterococcus was the dominant genus in CDI patients; in contrast, in healthy individuals, Faecalibacterium was the most abundant. The MaAsLin2 tool revealed that members of the family Enterococcaceae and the genus Enterococcus were more abundant in patients with CDI than in healthy individuals. Alpha and beta diversity did not reveal differences between the two study groups. Conclusions: We observed differences in microbiome patterns between healthy individuals and CDI patients that were consistent with the literature. Further studies are needed.